Erratum to: 'Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance' (J Hepatol 2019; 71(1): 14-24)

October 2020

Author(s): Merat SJ, Bru C, van de Berg D, Molenkamp R, Tarr AW, Koekkoek S, et al

Details: J Hepatol. 2020;73(4):999-1000

NIHR Acknowledged: Yes